DNA Immunization with a Herpes Simplex Virus 2 Bacterial Artificial Chromosome

Overview

Journal Virology

Specialty Microbiology

Date 2004 Feb 20

PMID 14972567

Citations 10

Authors

Clement A Meseda

Falko Schmeisser

Robin Pedersen

Amy Woerner

Jerry P Weir

Affiliations

Soon will be listed here.

Abstract

Construction of a herpes simplex virus 2 (HSV-2) bacterial artificial chromosome (BAC) is described. BAC vector sequences were inserted into the thymidine kinase gene of HSV-2 by homologous recombination. DNA from cells infected with the resulting recombinant virus was transformed into E. coli, and colonies containing the HSV-2 BAC (HSV2-BAC) were isolated and analyzed for the expected genotype. HSV2-BAC DNA was infectious when transfected back into mammalian cells and the resulting virus was thymidine kinase negative. When used to immunize mice, the HSV2-BAC DNA elicited a strong HSV-2 specific antibody response that was equal to or greater than live virus immunization. Further, HSV2-BAC immunization was protective when animals were challenged with a lethal dose of virus. The utility of the HSV2-BAC for construction of recombinant virus genomes was demonstrated by elimination of the HSV-2 glycoprotein D (gD) gene. A recombinant HSV-2 BAC with the gD gene deleted was isolated and shown to be incapable of producing infectious virus following transfection unless an HSV gD gene was expressed in a complementing cell line. Immunization of mice with the HSV2 gD-BAC also elicited an HSV-2 specific antibody response and was protective. The results demonstrate the feasibility of DNA immunization with HSV-2 bacterial artificial chromosomes for replicating and nonreplicating candidate HSV-2 vaccines, as well as the utility of BAC technology for construction and maintenance of novel HSV-2 vaccines. The results further suggest that such technology will be a powerful tool for dissecting the immune response to HSV-2.

Citing Articles

A Recombinant System and Reporter Viruses for Papiine Alphaherpesvirus 2.

Siregar A, Gartner S, Gotting J, Stegen P, Kaul A, Schulz T Viruses. 2022; 14(1).

PMID: 35062295 PMC: 8778148. DOI: 10.3390/v14010091.

Development of a BoHV-4 viral vector expressing tgD of BoHV-1 and evaluation of its immunogenicity in mouse model.

Bilge-Dagalp S, Farzani T, Dogan F, Akkutay Yoldar Z, Ozkul A, Alkan F Braz J Microbiol. 2021; 52(3):1119-1133.

PMID: 34255309 PMC: 8275906. DOI: 10.1007/s42770-021-00525-z.

Identification of the Cleavage Domain within Glycoprotein G of Herpes Simplex Virus Type 2.

Kropp K, Srivaratharajan S, Ritter B, Yu P, Krooss S, Polten F Viruses. 2020; 12(12).

PMID: 33322659 PMC: 7763493. DOI: 10.3390/v12121428.

Herpes Simplex Virus 2 Counteracts Neurite Outgrowth Repulsion during Infection in a Nerve Growth Factor-Dependent Manner.

Kropp K, Lopez-Munoz A, Ritter B, Martin R, Rastrojo A, Srivaratharajan S J Virol. 2020; 94(20).

PMID: 32669337 PMC: 7527038. DOI: 10.1128/JVI.01370-20.

A herpes simplex virus 2 glycoprotein D mutant generated by bacterial artificial chromosome mutagenesis is severely impaired for infecting neuronal cells and infects only Vero cells expressing exogenous HVEM.

Wang K, Kappel J, Canders C, Davila W, Sayre D, Chavez M J Virol. 2012; 86(23):12891-902.

PMID: 22993162 PMC: 3497698. DOI: 10.1128/JVI.01055-12.

References

Brune W, Menard C, Hobom U, Odenbreit S, Messerle M, Koszinowski U . Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis. Nat Biotechnol. 1999; 17(4):360-4. DOI: 10.1038/7914. View

Saeki Y, Ichikawa T, Saeki A, Chiocca E, Tobler K, Ackermann M . Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum Gene Ther. 1999; 9(18):2787-94. DOI: 10.1089/hum.1998.9.18-2787. View

Horsburgh B, Hubinette M, Tufaro F . Genetic manipulation of herpes simplex virus using bacterial artificial chromosomes. Methods Enzymol. 1999; 306:337-52. DOI: 10.1016/s0076-6879(99)06022-x. View

Smith G, Enquist L . A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis. Proc Natl Acad Sci U S A. 2000; 97(9):4873-8. PMC: 18325. DOI: 10.1073/pnas.080502497. View

Almazan F, Gonzalez J, Penzes Z, Izeta A, Calvo E, Plana-Duran J . Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A. 2000; 97(10):5516-21. PMC: 25860. DOI: 10.1073/pnas.97.10.5516. View

Pachl C, Burke R, Stuve L, Van Nest G, Masiarz F, Dina D . Expression of cell-associated and secreted forms of herpes simplex virus type 1 glycoprotein gB in mammalian cells. J Virol. 1987; 61(2):315-25. PMC: 253952. DOI: 10.1128/JVI.61.2.315-325.1987. View

Nass P, Elkins K, Weir J . Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins. J Infect Dis. 1998; 178(3):611-7. DOI: 10.1086/515374. View

Suter M, Lew A, Grob P, Adema G, Ackermann M, Shortman K . BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1. Proc Natl Acad Sci U S A. 1999; 96(22):12697-702. PMC: 23055. DOI: 10.1073/pnas.96.22.12697. View

Wagner M, Ruzsics Z, Koszinowski U . Herpesvirus genetics has come of age. Trends Microbiol. 2002; 10(7):318-24. DOI: 10.1016/s0966-842x(02)02394-6. View

10.

Horsburgh B, Hubinette M, Qiang D, MacDonald M, Tufaro F . Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes. Gene Ther. 1999; 6(5):922-30. DOI: 10.1038/sj.gt.3300887. View

11.

Messerle M, Crnkovic I, Hammerschmidt W, Ziegler H, Koszinowski U . Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A. 1998; 94(26):14759-63. PMC: 25110. DOI: 10.1073/pnas.94.26.14759. View

12.

Borst E, Hahn G, Koszinowski U, Messerle M . Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J Virol. 1999; 73(10):8320-9. PMC: 112849. DOI: 10.1128/JVI.73.10.8320-8329.1999. View

13.

Brune W, Messerle M, Koszinowski U . Forward with BACs: new tools for herpesvirus genomics. Trends Genet. 2000; 16(6):254-9. DOI: 10.1016/s0168-9525(00)02015-1. View

14.

Delecluse H, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W . Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A. 1998; 95(14):8245-50. PMC: 20961. DOI: 10.1073/pnas.95.14.8245. View

15.

Ligas M, Johnson D . A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells. J Virol. 1988; 62(5):1486-94. PMC: 253172. DOI: 10.1128/JVI.62.5.1486-1494.1988. View

16.

Domi A, Moss B . Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells. Proc Natl Acad Sci U S A. 2002; 99(19):12415-20. PMC: 129459. DOI: 10.1073/pnas.192420599. View

17.

Dolan A, Jamieson F, Cunningham C, Barnett B, McGeoch D . The genome sequence of herpes simplex virus type 2. J Virol. 1998; 72(3):2010-21. PMC: 109494. DOI: 10.1128/JVI.72.3.2010-2021.1998. View

18.

Denniston K, Madden M, Enquist L, Vande Woude G . Characterization of coliphage lambda hybrids carrying DNA fragments from Herpes simplex virus type 1 defective interfering particles. Gene. 1981; 15(4):365-78. DOI: 10.1016/0378-1119(81)90180-3. View

19.

Stavropoulos T, Strathdee C . An enhanced packaging system for helper-dependent herpes simplex virus vectors. J Virol. 1998; 72(9):7137-43. PMC: 109935. DOI: 10.1128/JVI.72.9.7137-7143.1998. View

20.

Meseda C, Elkins K, Merchlinsky M, Weir J . Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone. J Infect Dis. 2002; 186(8):1065-73. DOI: 10.1086/344234. View